Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Hematology

Symptoms, Warning Signs, and Systemic Complications

At a Glance

Dyskeratosis congenita can cause nail, skin, and mouth changes, but serious bone marrow, lung, and liver complications may occur without all three classic signs. Know your fever threshold and seek urgent care for bleeding, breathing trouble, or infection symptoms.

While Dyskeratosis Congenita (DC) was historically identified by three specific physical signs, we now know that it is a multisystem disorder that can affect almost any organ in the body [1][2]. Because it is a spectrum, you may have all, some, or even none of the classic physical symptoms while still having internal complications that require monitoring [3][4].

The Classic “Mucocutaneous Triad”

The mucocutaneous triad refers to three classic signs involving the skin, nails, and mouth [5]. These often appear in childhood, but their presence and severity vary widely [2][6].

  • Nail Dystrophy: This often starts as nails that are thin, split, or grow poorly. Over time, the nails may become very small or disappear entirely [5][7].
  • Skin Pigmentation: This typically looks like a “lacy” or reticulate pattern of darker and lighter patches, most commonly found on the neck and upper chest [5][8].
  • Oral Leukoplakia: These are persistent white patches in the mouth, often on the tongue or the inside of the cheeks [5][8]. It is important to have a specialist evaluate persistent patches, as they can sometimes develop into oral cancer [9].

It is important to remember that many people, especially those diagnosed in adulthood, do not have this full triad [3][4].

Major Systemic Complications

Because DC affects the body’s ability to renew tissues, several major organ systems are commonly at risk. Note that this list is not exhaustive; TBDs can also affect the eyes, immune system, skeleton, and endocrine systems. Normal findings in the lungs or liver do not mean you are free from significant disease elsewhere.

1. Bone Marrow Failure (BMF)

The bone marrow is the factory that makes your blood cells. In DC, this factory can slow down or stop working (aplastic anemia) [1][10]. This may start as a low count in just one type of cell—such as thrombocytopenia (low platelets)—before progressing to low counts across all blood types (pancytopenia) [10][11]. Low blood counts can lead to profound fatigue, severe infections, and life-threatening bleeding [12][13].

2. Pulmonary Fibrosis (Lung Scarring)

Over time, the lungs can develop scarring, known as pulmonary fibrosis, which makes it harder for the lungs to transfer oxygen to the blood [1][3]. Some patients may also develop hepatopulmonary syndrome, where blood vessels in the lungs widen abnormally, leading to low oxygen levels and shortness of breath [14][15].

3. Liver Disease

Liver issues in DC can include scarring (cirrhosis) or a condition called portal hypertension, which is high blood pressure in the vein that carries blood to the liver [6][16]. This can happen even if the liver itself doesn’t look severely scarred on some tests [16][14]. Portal hypertension can lead to fluid buildup in the abdomen or bleeding in the digestive tract [17][18].

Knowing When to Seek Urgent Care

Because DC can affect multiple systems at once, it is vital to know which symptoms require immediate action. Patients with bone marrow failure have very little reserve to fight infection or stop bleeding.

Category Routine (Discuss at next visit) Emergency (Go to ER / Call 911)
Hematologic (Blood) Mild bruising; feeling slightly more tired than usual. Fever (e.g., reaching your specific threshold, often 100.4°F/38.0°C) [13]. Uncontrolled bleeding; new red spots (petechiae) or sudden unexplained bruising; severe weakness or fainting [12].
Pulmonary (Lungs) Mild cough; getting winded more easily during exercise. New or worsening shortness of breath at rest; severe “air hunger”; blue tint to lips or nails (cyanosis); chest pain [19][14].
Hepatic (Liver) / GI Mild abdominal discomfort. Rapidly swelling stomach; significant new jaundice (yellow skin/eyes); vomiting blood (may look like coffee grounds); black, tarry, or bloody stools [6][18].

A Note on Emergency Room Care: If you must go to the emergency room, present a personalized emergency card detailing your diagnosis, your specific fever threshold, your baseline oxygen, and your blood-product requirements. Do not delay standard emergency stabilization, but explicitly ask the ER staff to consult your hematologist or TBD specialist concurrently, as your care may require center-specific adjustments [20][21].

Common questions in this guide

Which physical changes are typical of dyskeratosis congenita?
The three classic signs are nail dystrophy, meaning thin, splitting, or poorly growing nails; a lacy pattern of darker skin usually on the neck or upper chest; and persistent white patches in the mouth called oral leukoplakia. Their timing and severity can vary.
Can I have dyskeratosis congenita without the usual skin, nail, and mouth changes?
Yes. Dyskeratosis congenita is a spectrum disorder, so a person may have only some of the three classic signs or none of them, especially when diagnosed as an adult. The absence of these visible changes does not rule out internal complications or remove the need for monitoring.
What serious organ complications can dyskeratosis congenita cause?
Dyskeratosis congenita can cause bone marrow failure, leading to low blood counts, fatigue, severe infections, and dangerous bleeding. It can also cause lung scarring or low oxygen and liver problems such as cirrhosis or portal hypertension, which is high pressure in the vein leading to the liver.
Which dyskeratosis congenita symptoms mean I should seek emergency care?
Seek emergency care for fever at your personal threshold, often 100.4°F or 38°C, uncontrolled bleeding, sudden tiny red spots or bruising, severe weakness or fainting, new or worsening shortness of breath at rest, blue lips or nails, or chest pain. Rapidly increasing abdominal swelling, significant jaundice, vomiting blood, or black, tarry, or bloody stools are also emergencies.
Why should persistent white patches in the mouth be checked?
Persistent white patches on the tongue or inside the cheeks should be assessed by a specialist. In dyskeratosis congenita, oral leukoplakia can sometimes progress to oral cancer, so ongoing or changing patches should not be ignored.
Can dyskeratosis congenita affect the lungs or liver even when tests seem normal?
Yes. Dyskeratosis congenita can cause pulmonary fibrosis, which is scarring of the lungs, or hepatopulmonary syndrome, which can lower oxygen levels; it can also cause cirrhosis or portal hypertension. A normal lung or liver finding does not exclude important disease in another organ system, so monitoring should follow your specialist's plan.
What information should I bring to the emergency room if I have DC?
Bring an emergency card listing your dyskeratosis congenita diagnosis, personal fever threshold, baseline oxygen level, blood-product requirements, and hematologist or specialist contact information. Do not delay emergency stabilization, and ask the emergency team to consult your hematologist or dyskeratosis congenita specialist when possible.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.I have noticed [specific change, e.g., thin nails or skin spots]; does this count as part of the classic triad, and does it change my monitoring plan?
  2. 2.What is my specific 'fever threshold' (e.g., 100.4°F), and what is the exact emergency protocol I should follow if I reach it?
  3. 3.Given my genetic results, am I at higher risk for early lung or liver complications, and when should we start baseline testing for these?
  4. 4.If I go to the emergency room, how can I ensure the ER physicians consult with you before making treatment decisions?
  5. 5.Who on the specialist team should I contact first if I experience worsening shortness of breath or a drop in my oxygen levels?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Dyskeratosis congenita and telomere biology disorders.

    Savage SA

    Hematology. American Society of Hematology. Education Program 2022; (2022(1)):637-648 doi:10.1182/hematology.2022000394.

    PMID: 36485133
  2. 2

    Beginning at the ends: telomeres and human disease.

    Savage SA

    F1000Research 2018; (7()) doi:10.12688/f1000research.14068.1.

    PMID: 29770205
  3. 3

    [Dyskeratosis congenita combined with myeloproliferative disorder and trilineage cytopenia].

    Peng YL, Qian XT, Tian YQ, et al.

    Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 2025; (48(6)):540-547 doi:10.3760/cma.j.cn112147-20241010-00593.

    PMID: 40491143
  4. 4

    Telomere biology disorders may manifest as common variable immunodeficiency (CVID).

    Rolles B, Caballero-Oteyza A, Proietti M, et al.

    Clinical immunology (Orlando, Fla.) 2023; (257()):109837 doi:10.1016/j.clim.2023.109837.

    PMID: 37944684
  5. 5

    Two Cases of Dyskeratosis Congenita with Clinically Distinct Presentations, Seen in National University Hospital, Singapore.

    Juay L, Chandran NS

    Skin appendage disorders 2022; (8(1)):53-56 doi:10.1159/000518299.

    PMID: 35111818
  6. 6

    Progression of liver disease and portal hypertension in dyskeratosis congenita and related telomere biology disorders.

    Vittal A, Niewisch MR, Bhala S, et al.

    Hepatology (Baltimore, Md.) 2023; (78(6)):1777-1787 doi:10.1097/HEP.0000000000000461.

    PMID: 37184208
  7. 7

    Siblings with a Homozygous Variant in the NHP2 Gene: A Case Report and Review of Literature.

    Sürücü Kara İ, Duman D, Bademci G, et al.

    Molecular syndromology 2025; (16(6)):559-567 doi:10.1159/000543315.

    PMID: 40352450
  8. 8

    Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report.

    Ratnasamy V, Navaneethakrishnan S, Sirisena ND, et al.

    BMC medical genetics 2018; (19(1)):85 doi:10.1186/s12881-018-0584-y.

    PMID: 29801475
  9. 9

    An update on the biology and management of dyskeratosis congenita and related telomere biology disorders.

    Niewisch MR, Savage SA

    Expert review of hematology 2019; (12(12)):1037-1052 doi:10.1080/17474086.2019.1662720.

    PMID: 31478401
  10. 10

    de Novo TINF2 C.845G>A: Pathogenic Variant in Patient with Dyskeratosis Congenita.

    Kocheva SA, Gjorgjievska M, Martinova K, et al.

    Balkan journal of medical genetics : BJMG 2021; (24(2)):89-93 doi:10.2478/bjmg-2021-0027.

    PMID: 36249522
  11. 11

    Clinical features of dyskeratosis congenita in mainland China: case reports and literature review.

    Li F, Li W, Qiao X, Xie X

    International journal of hematology 2019; (109(3)):328-335 doi:10.1007/s12185-018-02582-x.

    PMID: 30604317
  12. 12

    Revisiting the first reported case of aplastic anaemia.

    Steensma DP

    British journal of haematology 2024; (204(2)):455-458 doi:10.1111/bjh.19241.

    PMID: 38044033
  13. 13

    Frosted Branch Angiitis in Pediatric Dyskeratosis Congenita: A Case Report.

    Zheng XY, Xu J, Li W, et al.

    Medicine 2016; (95(12)):e3106 doi:10.1097/MD.0000000000003106.

    PMID: 27015183
  14. 14

    Hepatopulmonary syndrome is a frequent cause of dyspnea in the short telomere disorders.

    Gorgy AI, Jonassaint NL, Stanley SE, et al.

    Chest 2015; (148(4)):1019-1026 doi:10.1378/chest.15-0825.

    PMID: 26158642
  15. 15

    Treatment of telomeropathies.

    Vieri M, Brümmendorf TH, Beier F

    Best practice & research. Clinical haematology 2021; (34(2)):101282 doi:10.1016/j.beha.2021.101282.

    PMID: 34404536
  16. 16

    Spectrum of Liver Pathology in Dyskeratosis Congenita.

    Putra J, Agarwal S, Al-Ibraheemi A, et al.

    The American journal of surgical pathology 2023; (47(8)):869-877 doi:10.1097/PAS.0000000000002060.

    PMID: 37246821
  17. 17

    Gastrointestinal Hemorrhage: A Manifestation of the Telomere Biology Disorders.

    Himes RW, Chiou EH, Queliza K, et al.

    The Journal of pediatrics 2021; (230()):55-61.e4 doi:10.1016/j.jpeds.2020.09.038.

    PMID: 32971146
  18. 18

    TERT de novo mutation-associated dyskeratosis congenita and porto-sinusoidal vascular disease: a case report.

    Yu G, Xin G, Liu X, et al.

    Journal of medical case reports 2025; (19(1)):32 doi:10.1186/s13256-025-05031-6.

    PMID: 39849589
  19. 19

    Tissue-specific telomere shortening and degenerative changes in a patient with TINF2 mutation and dyskeratosis congenita.

    Roake CM, Juntilla M, Agarwal-Hashmi R, et al.

    Human pathology (New York) 2021; (25()) doi:10.1016/j.ehpc.2021.200517.

    PMID: 34522616
  20. 20

    TeloNet is born: why all specialities need to be aware of telomere biology disorders.

    Longhurst HJ, Paxton JK, Tummala H, et al.

    Frontiers in medicine 2026; (13()):1780232 doi:10.3389/fmed.2026.1780232.

    PMID: 42110436
  21. 21

    Diagnosis and management of adult telomere biology disorders.

    Franke M, Ferrer A, Patnaik MM

    Haematologica 2026; (111(3)):797-812 doi:10.3324/haematol.2025.287739.

    PMID: 41035407

This page is for informational purposes only and does not constitute medical advice about dyskeratosis congenita. Contact your hematologist or specialist team for individualized monitoring and emergency instructions.

Get notified when new evidence is published on Dyskeratosis congenita.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.